Selective estrogen receptor modulators for the treatment of vasomotor symptoms

Details for Australian Patent Application No. 2005207821 (hide)

Owner Eli Lilly and Company

Inventors Hinklin, Ronald Jay; Shepherd, Timothy Alan; Dodge, Jeffrey Alan; Wallace, Owen Brendan; Frank, Scott Alan; Dally, Robert Dean

Agent Spruson & Ferguson

Pub. Number AU-B-2005207821

PCT Pub. Number WO2005/073204

Priority 60/538,342 22.01.04 US; 60/538,442 22.01.04 US

Filing date 18 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 10 February 2011

International Classifications

C07D 221/18 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 295/092 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 311/78 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 335/04 (2006.01) Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/073204 Priority application(s): WO2005/073204

10 February 2011 Application Accepted

  Published as AU-B-2005207821

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207832-Combustible product and package

2005207817-Novel piperidines as chemokine modulators (CCR)